Results 121 to 130 of about 108,387 (211)

The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria. [PDF]

Allergy Asthma Immunol Res, 2020
Choi JH, Lee DH, Song WJ, Choi M, Kwon JW, Kim GW, Kim MH, Kim MA, Kim MH, Kim BK, Kim S, Kim JS, Kim JE, Kim JY, Kim JH, Kim HJ, Kim HO, Kim HB, Roh JY, Park KH, Park KY, Park HK, Park H, Bae JM, Byun JY, Song DJ, Ahn YM, Lee SE, Lee YB, Lee JS, Lee JH, Lim KH, Youn SW, Chang YS, Jeon YH, Jeon J, Jue MS, Choi SH, Hur GY, Lim DH, Ye YM, Park YM.   +41 more
europepmc   +1 more source

Solar urticaria in the visible spectrum successfully treated with astemizole [PDF]

, 1990
Three cases of solar urticaria in the visible spectrum successfully treated with astemizole, a H1 antihistamine, are reported.
MONFRECOLA, GIUSEPPE, Nappa P, Pini D.
core  

Allergic conjunctivitis and H1 antihistamines.

Journal of investigational allergology & clinical immunology, 2009
Allergic conjunctivitis is the most common form of ophthalmological allergy. Eye symptoms are one of the main and most frequent reasons for consultation among patients with allergic rhinoconjunctivitis, which in turn is the most common reason for visiting the allergologist, according to the Alergológica 2005 study.
A, del Cuvillo, J, Sastre, J, Montoro, I, Jáuregui, I, Dávila, M, Ferrer, J, Bartra, J, Mullol, A, Valero   +8 more
openaire   +1 more source

Antipruritic Placebo Effects by Conditioning H1-antihistamine. [PDF]

Psychosom Med, 2019
Meeuwis SH, van Middendorp H, Pacheco-Lopez G, Ninaber MK, Lavrijsen APM, van der Wee N, Veldhuijzen DS, Evers AWM.   +7 more
europepmc   +1 more source

Oral Second-Generation H1-Antihistamine Regimens for Allergic Rhinitis: Systematic Review and Network Meta-Analysis of Effects and Estimability. [PDF]

J Clin Med
Maya Viejo JD, Navarro I Ros FM, Trillo-Calvo E, Rodríguez LR.   +3 more
europepmc   +1 more source

Effective treatment of different H1-antihistamine-refractory chronic urticaria phenotypes with omalizumab. [PDF]

Turk Pediatri Ars, 2018
Uysal P, Erge D.
europepmc   +1 more source

<i>In silico</i> Evaluation of H1-Antihistamine as Potential Inhibitors of SARS-CoV-2 RNA-dependent RNA Polymerase: Repurposing Study of COVID-19 Therapy. [PDF]

Turk J Pharm Sci
Hamdan M, Kulabaş N, Küçükgüzel İ.
europepmc   +1 more source

Association of concomitant H1 antihistamine and immune checkpoint inhibitor therapy on survival outcome and safety in patients with advanced primary lung cancer: a cohort study. [PDF]

Transl Lung Cancer Res
Zhang WH, Li BX, Ma CX, Wang J, Yang F, Xiong YJ, Li SZ, Zhang JL, Du WJ, Hui ZZ, Shen M, Zhou L, Li RM, Tian X, Han Y, Ren BZ, Ichiki Y, Lee SC, Zhang XW, Cao S, Ren XB, Liu L.   +21 more
europepmc   +1 more source

Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study. [PDF]

Front Immunol
Fukunaga A, Kakei Y, Murakami S, Kan Y, Masuda K, Jinnin M, Washio K, Amano H, Nagano T, Yamamoto A, Otsuka T, Takahagi S, Takenaka M, Ishiguro N, Hayama K, Inomata N, Nakagawa Y, Sugiyama A, Hide M.   +18 more
europepmc   +1 more source

Surveillance of First-Generation H1-Antihistamine Use for Older Patients with Dementia in Japan: A Retrospective Cohort Study. [PDF]

Curr Gerontol Geriatr Res, 2018
Maeda T, Babazono A, Nishi T.
europepmc   +1 more source